Augmentation with buspirone: a review.
Augmentation with buspirone: a review.
复制标题
DOI：
10.3109/10401239509149042
复制
发表时间：
1995-09-01
期刊：
影响因子：
--
通讯作者：
Balon, R
中科院分区：
文献类型：
--
作者：
Harvey, K V;Balon, R
丁螺环酮是一种阿兹匹尔酮5-羟色胺（5-HT） 1A部分激动剂，已被FDA批准为抗焦虑药。它已经被测试用于抑郁症、恐慌症、强迫症和精神分裂症。几项试验表明，它可能被证明是一种有用的药物，以增加其他精神药物对这些疾病。我们回顾了支持丁螺环酮作为增强剂的潜在用途的文献。
Buspirone, an azaspirone serotonin (5-HT) 1A partial agonist, has been approved by the FDA as an anxiolytic. It has been tested for use in depression, panic disorder, obsessive-compulsive disorder, and schizophrenia as well. Several trials have indicated that it may prove to be a useful agent for augmentation of other psychotropic medications in these disorders. We review the literature supporting the potential use of buspirone as an augmenting agent.